NPs Basic Information

Name
Citrinin
Molecular Formula C13H14O5
IUPAC Name*
(3R,4S)-6-hydroxy-3,4,5-trimethyl-8-oxo-3,4-dihydroisochromene-7-carboxylic acid
SMILES
C[C@@H]1[C@H](OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C
InChI
InChI=1S/C13H14O5/c1-5-7(3)18-4-8-9(5)6(2)11(14)10(12(8)15)13(16)17/h4-5,7,14H,1-3H3,(H,16,17)/t5-,7-/m1/s1
InChIKey
CBGDIJWINPWWJW-IYSWYEEDSA-N
Synonyms
citrinin; 518-75-2; (-)-citrinin; Citriain; (3R,4S)-4,6-Dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran-7-carboxylic acid; 4,6-Dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran-7-carboxylic acid; NSC186; 3H-2-Benzopyran-7-carboxylic acid, 4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-, (3R-trans)-; 3S697X6SNZ; CHEBI:48707; NSC-186; (3R,4S)-6-hydroxy-3,4,5-trimethyl-8-oxo-3,4-dihydroisochromene-7-carboxylic acid; (3R,4S)-8-hydroxy-3,4,5-trimethyl-6-oxo-4,6-dihydro-3H-isochromene-7-carboxylic acid; (3R-trans)-4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran-7-carboxylic acid; Citrinin 100 microg/mL in Acetonitrile; 3H-2-Benzopyran-7-carboxylic acid, 4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-, (3R,4S)-; (3R,4S)-8-hydroxy-3,4,5-trimethyl-6-oxo-3,4-dihydroisochromene-7-carboxylic acid; CCRIS 175; HSDB 3473; EINECS 208-257-2; BRN 0088597; UNII-3S697X6SNZ; 3,4-Dihydro-8-hydroxy-3,4,5-trimethyl-6H-6-oxobenzo(c)pyran-7-carboxylic acid; MFCD00006912; Citrinin, 98%; Spectrum_000451; CITRININ [HSDB]; CITRININ [IARC]; CITRININ [MI]; Spectrum2_000734; Spectrum3_000240; Spectrum4_001804; Spectrum5_000507; BSPBio_001919; KBioGR_002411; KBioSS_000931; SPECTRUM210186; 5-18-09-00061 (Beilstein Handbook Reference); DivK1c_000646; SCHEMBL157775; SPBio_000688; DTXSID8020333; HMS502A08; KBio1_000646; KBio2_000931; KBio2_003499; KBio2_006067; KBio3_001419; NINDS_000646; HMS1923C05; CCG-39048; ZINC19795941; AKOS030254668; SDCCGMLS-0066537.P001; IDI1_000646; NCGC00160164-01; NCGC00160164-02; NCGC00160164-03; NCI60_001544; E80637; Q420354; SR-05000002496; WLN: T66 CO HV AUT&J D1 E1 G1 IVQ JQ; SR-05000002496-1; Citrinin, from Penicillium citrinum, >=98% (HPLC); Q63392265; (3R,4S)-3,4,5-Trimethyl-6-hydroxy-8-oxo-4,8-dihydro-3H-2-benzopyran-7-carboxylic acid; (3R,4S)-6-hydroxy-3,4,5-trimethyl-8-oxo-4,8-dihydro-3H-2-benzopyran-7-carboxylic acid; 3H-2-Benzopyran-7-carboxylic acid, 4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-; 8-Hydroxy-3,4,5-trimethyl-6-oxo-4,6-dihydro-3H-isochromene-7-carboxylic acid #; 3H-2-Benzopyran-7-carboxylic acid, 4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-,(3R,4S)-; 3H-2-Benzopyran-7-carboxylic acid,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-, (3R-trans)-; 4,6-Dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo, (3R-trans)-3H-2-benzopyran-7-carboxylic acid
CAS 518-75-2
PubChem CID 54680783
ChEMBL ID CHEMBL510139
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Benzopyrans
        • Subclass: No Rank at Level Subclass
          • Direct Parent: Benzopyrans

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 250.25 ALogp: 1.7
HBD: 2 HBA: 5
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 83.8 Aromatic Rings: 2
Heavy Atoms: 18 QED Weighted: 0.697

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.628 MDCK Permeability: 0.00000230
Pgp-inhibitor: 0 Pgp-substrate: 0.018
Human Intestinal Absorption (HIA): 0.018 20% Bioavailability (F20%): 0.004
30% Bioavailability (F30%): 0.003

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.037 Plasma Protein Binding (PPB): 93.77%
Volume Distribution (VD): 0.949 Fu: 6.20%

ADMET: Metabolism

CYP1A2-inhibitor: 0.227 CYP1A2-substrate: 0.571
CYP2C19-inhibitor: 0.033 CYP2C19-substrate: 0.061
CYP2C9-inhibitor: 0.065 CYP2C9-substrate: 0.167
CYP2D6-inhibitor: 0.03 CYP2D6-substrate: 0.125
CYP3A4-inhibitor: 0.051 CYP3A4-substrate: 0.067

ADMET: Excretion

Clearance (CL): 1.593 Half-life (T1/2): 0.888

ADMET: Toxicity

hERG Blockers: 0.007 Human Hepatotoxicity (H-HT): 0.598
Drug-inuced Liver Injury (DILI): 0.984 AMES Toxicity: 0.402
Rat Oral Acute Toxicity: 0.217 Maximum Recommended Daily Dose: 0.025
Skin Sensitization: 0.367 Carcinogencity: 0.953
Eye Corrosion: 0.004 Eye Irritation: 0.336
Respiratory Toxicity: 0.872
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC002338 0.554 D0S0LZ 0.236
ENC000945 0.391 D0K7LU 0.231
ENC003584 0.309 D07JGT 0.224
ENC004363 0.309 D0JL2K 0.216
ENC001362 0.305 D08NQZ 0.213
ENC004391 0.305 D0YH0N 0.212
ENC000670 0.290 D0B9EJ 0.211
ENC003525 0.290 D0X9ZC 0.211
ENC004991 0.290 D0R6RC 0.209
ENC004969 0.290 D0J2NK 0.209
*Note: the compound similarity was calculated by RDKIT.